Waltham, MA, November 15, 2022 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its second annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital patient experiences. The novel study evaluates the brands across five categories and 60 unique metrics to understand each one’s digital marketing presence.
The Digital Marketing Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It also examines the influence of…
Read Now
Upcoming Webinar “Business Development: Getting Pricing & Access Inputs Right” Tackles the Most Common High-Impact Challenges Inherent in Business Development
Waltham, MA, October 27, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces Quick Payer Pulse—a proprietary survey tool that generates and quantifies country-specific payer insights to support time-sensitive business needs. In life sciences, pricing and access are vital to an asset’s success globally. As assets go through earlier development phases or M&A processes, there…
Read Now
“Patient Journey: A New Approach to Meet the Demands of Patient Centricity” Available Now from Trinity Life Sciences
Waltham, MA, September 27, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, outlines a new approach to Patient Journey that allows patient-centric organizations to engage on a meaningful level with patients. As patients continue to expand their role in healthcare choice and treatment decision-making, expectations have grown for pharma to provide an experience in line with well-known,…
Read Now
Waltham, MA, September 6, 2022 — Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Maia Germain as Chief People Officer (CPO) and a member of the executive operating committee, reporting directly to Rebecca McNamara, Trinity’s CFO and Head of Corporate Operations.
Ms. Germain has a proven track record for leading high-growth companies through transformation and building positive employee cultures that serve the overall business. She joins Trinity after holding Senior Vice President roles…
Read Now
The Listing is a Second Year Honor for the Company
Waltham, MA, August 17, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it was named to the 2022 Inc. 5000 fastest-growing private companies list. This is the second year in a row Trinity has been included on the prestigious list. The Inc. 5000 list represents a one-of-a-kind look at the most successful companies within the economy’s most dynamic segment – its independent businesses.
“Our…
Read Now
The partnership pairs Bain’s extensive experience across the global life sciences value chain with Trinity’s specialized, evidence-based solutions for life sciences companies
BOSTON, Aug. 8, 2022 /PRNewswire/ — Bain & Company, a top global management consultancy, and Trinity Life Sciences, a leader in global life sciences commercialization solutions, have announced a strategic partnership to bring together Bain’s extensive global experience across the life sciences value chain with Trinity’s deep technical expertise in biopharma and medtech. The partnership includes Bain & Company taking a minority investment…
Read Now
Asset Acquisition Enables Trinity to Better Connect with Healthcare Professionals
Waltham, MA, August 4, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced it signed an asset purchase agreement for the acquisition of Vancery’s customer research technology. The investment expands Trinity’s insights and analytics product offerings, allowing the company to better connect with healthcare professionals to inform commercial strategy for its clients. The new technology will improve primary market research in the life sciences by…
Read Now
Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio
Waltham, MA, July 19, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more…
Read Now
Commerical Teams in the Life Sciences Need a Gradual, Stepwise Approach to Product Launches to Achieve Success, according to a New White Paper Available Now from Trinity Life Sciences
Waltham, MA, June 29, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that 62 percent of biopharma products that launched between September 2019 and December 2021 underperformed expectations, including 24 out of 28 non-rare, non-oncology products. According to a new white paper entitled Empowering the…
Read Now
Webinar Entitled “Reimagining Work Models in the Life Sciences: Implications for the Future of Work” Will be Held on June 23
Waltham, MA, June 21, 2022 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its latest TGaS report entitled, Reimagining Work Models in the Life Sciences: Implications for the Future of Work. The study is the first of its kind for the life sciences industry as it provides objective data to help companies make informed…
Read Now
